Rayner Announces New CEO

Rayner Intraocular Lenses Limited announced today the appointment Martin Jamieson as its new Chief Executive Officer (CEO.) Most recently, Mr. Jamieson was Managing Director of Smiths Medical International, a company employing 2,400 worldwide with a turnover of over £400 million.

Rayner lens Chairman Donald Munro said: "I am very pleased to welcome Martin as our new CEO. This is a new position in the company comes at a pivotal moment in our development as we move our manufacturing facility and offices from Hove to Worthing.  Martin has an impressive record in senior management within the UK medical device industry, experience which Rayner needs now in order to capitalise on our recent successes and build a strong business for the future.”

Mr. Jamieson has had an accomplished career in the medical devices sector. As CEO he will take immediate charge of Rayner’s business, with a special emphasis on managing the important transition to the company’s new site in Worthing.

Mr Munro added: “I will move to a new role as Vice President – re-focusing on our external activities, maintaining and developing our well-established links with the ophthalmic surgeon community, as well as our links with the industry and our network of international distributors.”

Mr Jamieson said: "I am proud to be joining Rayner - a unique company in many respects - a Queen's Award for Enterprise (2009) winner that has continued to show vigorous growth in recent years. I recognise I am joining the pioneers of IOL manufacturing but I see Rayner also as a company poised for a great destiny as a 21st Century medical device global business, based in Sussex. I look forward to leading the Company successfully through the challenges which lie ahead."

Mr. Jamieson is a Non-Executive Director of Medway Hospital Trust. He will assume his new position at Rayner in early May.

-END-

About Rayner Intraocular Lenses Ltd.

Rayner, the pioneering intraocular lens (IOL) manufacturer has over 60-years of dedication to improving vision and the restoration of sight worldwide. With an unrivalled history of commitment to the advancement of IOL technology, Rayner had the unique honour of manufacturing the world’s first IOL.

Rayner is the first and only IOL manufacturer to receive the Queen’s Award for Enterprise in International Trade (2009). Rayner’s injectable hydrophyllic IOLs are designed for both patient and practitioner ease and comfort, and are available in monofocal, multifocal, toric, supplementary and customized varieties. Headquartered in Hove, East Sussex, United Kingdom, Rayner markets its IOL products worldwide through a network of distributors.

For further information, please contact:

Kristine Morrill at Kommunica @ medeuronet UK Ltd.

Email: kmorrill@medeuronet.com

Phone : +44 7787 137 962